Status:
COMPLETED
Multidimensional Measurement of Psychopharmacological Treatment Response
Lead Sponsor:
Child Psychopharmacology Institute
Conditions:
Autism Spectrum Disorders
Mood Disorders
Eligibility:
All Genders
6+ years
Brief Summary
The study examines actigraphic, observational, psychometric and associated repeated measurements obtained prior to and during psychopharmacological treatment.
Detailed Description
Baseline actigraphic measurements, multi-symptom operationally defined observations and psychometric data will be established and repeated to measure treatment response. Additional biological and biom...
Eligibility Criteria
Inclusion
- Diagnosis of:
- Autism Spectrum Disorder
- Mood Disorder
- Attention Deficit Hyperactivity Disorder
- Unaffected First Degree Relative of Study Subject
- Anticipation of pharmacological intervention or current pharmacological intervention
Exclusion
- Inability to wear an actigraphy watch
Key Trial Info
Start Date :
August 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2011
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT01184235
Start Date
August 1 2010
End Date
August 1 2011
Last Update
January 6 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Child Psychopharmacology Institute
Fargo, North Dakota, United States, 58103